The 2012 Jeffrey M. Trent Lectureship in Cancer Research

National Human Genome Research Institute

National Institutes of Health
U.S. Department of Health and Human Services


The 2012 Jeffrey M. Trent Lectureship in Cancer Research

Cancer Genomes and Their Implications for Basic and Applied Research

Bert Vogelstein, M.D.

The 10th annual Jeffrey M. Trent Lectureship in Cancer Research will be held on Wednesday, February 29, 2012, at 10 a.m.. The presenter is Bert Vogelstein, M.D., Clayton Professor of Oncology and Pathology, and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine. Dr. Vogelstein is also a Howard Hughes Medical Institute investigator. The lecture is convened by the National Human Genome Research Institute's Division of Intramural Research, and will be held at the Natcher Conference Center (Building 45) on the National Institutes of Health (NIH) campus in Bethesda, Md.


About the Lecturer

Dr. Vogelstein was the first researcher to elucidate the molecular basis of a common human cancer. His work on colorectal cancers forms the paradigm for much of modern cancer research, with profound implications for diagnostic and therapeutic strategies in the future.

Excellent academic and medical training set the foundation for Dr. Vogelstein's illustrious science career. He earned his medical degree at the Johns Hopkins University School of Medicine and completed his residency in pediatrics at the Johns Hopkins Hospital. Following his clinical training, Dr. Vogelstein also completed a post-doctoral fellowship at the National Cancer Institute, focusing on the development of new approaches to the study of human cancers.

Dr. Vogelstein has received numerous awards recognizing his pioneering studies on the pathogenesis of human cancers. He is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, the American Philosophical Society, the Institute of Medicine and the European Molecular Biology Organization (EMBO). His advisory roles have included chairmanships for the National Research Council Committee on the Biological and Biomedical Applications of Stem Cell Research and the Board of Scientific Counselors of the National Human Genome Research Institute (NHGRI). According to the Institute for Scientific Information, Dr. Vogelstein is currently the most highly cited scientist in the world.

About the Jeffrey M. Trent Lectureship in Cancer Research

Dr. Trent was the National Human Genome Research Institute's founding scientific director, serving in this role for more than nine years. His leadership and vision was instrumental in establishing NHGRI's Division of Intramural Research as one of the premier research programs in the world devoted to genetics and genomics. In recognition of his significant contributions to the research environment at NIH, NHGRI established the annual Jeffrey M. Trent Lectureship in Cancer Research in 2003. This lecture is given by a prominent cancer researcher who brings the kind of energy, creativity and enthusiasm to cancer research that Dr. Trent has exemplified throughout his career.

More information about Dr. Vogelstein and his research can be found at:

For additional information:

Karen Tilghman
E-mail: tilghmank@mail.nih.gov
Phone: (301) 451-9648

Top of page

Last Reviewed: November 14, 2012